These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28327546)

  • 1. Missense mutations near the N-glycosylation site of the A2 domain lead to various intracellular trafficking defects in coagulation factor VIII.
    Wei W; Zheng C; Zhu M; Zhu X; Yang R; Misra S; Zhang B
    Sci Rep; 2017 Mar; 7():45033. PubMed ID: 28327546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of missense mutations that generate ectopic N-glycosylation sites in coagulation factor VIII.
    Wei W; Misra S; Cannon MV; Yang R; Zhu X; Gilmore R; Zhu M; Zhang B
    Biochem J; 2018 Mar; 475(5):873-886. PubMed ID: 29444815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular basis for cross-reacting material-positive hemophilia A due to missense mutations within the A2-domain of factor VIII.
    Amano K; Sarkar R; Pemberton S; Kemball-Cook G; Kazazian HH; Kaufman RJ
    Blood; 1998 Jan; 91(2):538-48. PubMed ID: 9427707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of five associations of F8 missense mutations containing FVIII B domain mutations.
    Jourdy Y; Nougier C; Roualdes O; Fretigny M; Durand B; Negrier C; Vinciguerra C
    Haemophilia; 2016 Jul; 22(4):583-9. PubMed ID: 26915717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor VIII A3 domain substitution N1922S results in hemophilia A due to domain-specific misfolding and hyposecretion of functional protein.
    Summers RJ; Meeks SL; Healey JF; Brown HC; Parker ET; Kempton CL; Doering CB; Lollar P
    Blood; 2011 Mar; 117(11):3190-8. PubMed ID: 21217077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Most factor VIII B domain missense mutations are unlikely to be causative mutations for severe hemophilia A: implications for genotyping.
    Ogata K; Selvaraj SR; Miao HZ; Pipe SW
    J Thromb Haemost; 2011 Jun; 9(6):1183-90. PubMed ID: 21645226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor VIII C2 domain missense mutations exhibit defective trafficking of biologically functional proteins.
    Pipe SW; Kaufman RJ
    J Biol Chem; 1996 Oct; 271(41):25671-6. PubMed ID: 8810344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of Factor VIII A2 Domain Residues 400-409 to a Factor X-Interactive Site in the Factor Xase Complex.
    Takeyama M; Nogami K; Sasai K; Furukawa S; Shima M
    Thromb Haemost; 2018 May; 118(5):830-841. PubMed ID: 29614522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico calculated affinity of FVIII-derived peptides for HLA class II alleles predicts inhibitor development in haemophilia A patients with missense mutations in the F8 gene.
    Pashov AD; Calvez T; Gilardin L; Maillère B; Repessé Y; Oldenburg J; Pavlova A; Kaveri SV; Lacroix-Desmazes S
    Haemophilia; 2014 Mar; 20(2):176-84. PubMed ID: 24118514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for hemophilia A caused by mutations in the C domains of blood coagulation factor VIII.
    Gale AJ; Pellequer JL; Getzoff ED; Griffin JH
    Thromb Haemost; 2000 Jan; 83(1):78-85. PubMed ID: 10669159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in baseline factor VIII concentration in a retrospective cohort of mild/moderate hemophilia A patients carrying identical F8 mutations.
    Loomans JI; van Velzen AS; Eckhardt CL; Peters M; Mäkipernaa A; Holmstrom M; Brons PP; Dors N; Haya S; Voorberg J; van der Bom JG; Fijnvandraat K
    J Thromb Haemost; 2017 Feb; 15(2):246-254. PubMed ID: 27943580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico and in vitro evaluation of the impact of mutations in non-severe haemophilia A patients on assay discrepancies.
    Pezeshkpoor B; Gazorpak M; Berkemeier AC; Singer H; Pavlova A; Biswas A; Oldenburg J
    Ann Hematol; 2019 Aug; 98(8):1855-1865. PubMed ID: 30997536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of F8 B domain gene variants on synthesis, secretion, activity and stability of factor VIII protein.
    Pahl S; Pavlova A; Driesen J; Oldenburg J
    Thromb Haemost; 2014 Jan; 111(1):58-66. PubMed ID: 24108539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemophilia A mutations in patients with non-severe phenotype associated with a discrepancy between one-stage and chromogenic factor VIII activity assays.
    Pavlova A; Delev D; Pezeshkpoor B; Müller J; Oldenburg J
    Thromb Haemost; 2014 May; 111(5):851-61. PubMed ID: 24452774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioengineering of coagulation factor VIII for improved secretion.
    Miao HZ; Sirachainan N; Palmer L; Kucab P; Cunningham MA; Kaufman RJ; Pipe SW
    Blood; 2004 May; 103(9):3412-9. PubMed ID: 14726380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor VIII (FVIII) gene mutations in 120 patients with hemophilia A: detection of 26 novel mutations and correlation with FVIII inhibitor development.
    Repessé Y; Slaoui M; Ferrandiz D; Gautier P; Costa C; Costa JM; Lavergne JM; Borel-Derlon A
    J Thromb Haemost; 2007 Jul; 5(7):1469-76. PubMed ID: 17445092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional mapping of the A2 domain from human factor VIII.
    Plantier JL; Saboulard D; Pellequer JL; Négrier C; Delcourt M
    Thromb Haemost; 2012 Feb; 107(2):315-27. PubMed ID: 22234396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico analyses of missense mutations in coagulation factor VIII: identification of severity determinants of haemophilia A.
    Sengupta M; Sarkar D; Ganguly K; Sengupta D; Bhaskar S; Ray K
    Haemophilia; 2015 Sep; 21(5):662-9. PubMed ID: 25854144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor VIII Ise (R2159C) in a patient with mild hemophilia A, an abnormal factor VIII with retention of function but modification of C2 epitopes.
    Suzuki H; Shima M; Arai M; Kagawa K; Fukutake K; Kamisue S; Nakai H; Morichika S; Tanaka I; Inoue M; Gale K; Tuddenham EG; Yoshioka A
    Thromb Haemost; 1997 May; 77(5):862-7. PubMed ID: 9184393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood coagulation factor VIII D1241E polymorphism leads to a weak malectin interaction and reduction of factor VIII posttranslational modification and secretion.
    Jiang N; Xiao Y; Liu Y; Liu W; Liu S
    Exp Cell Res; 2020 Dec; 397(1):112334. PubMed ID: 33144078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.